Gold Prices Fall as Hot U.S. Inflation Boosts Fed Rate Hike Bets 
White House Defends Trump’s FIFA Peace Prize Amid Global Criticism 
Oil Prices Surge as Houthi Attacks Deepen Hormuz Supply Fears 
SpaceX Nasdaq 100 Weight Set to More Than Double 
Milei Pushes for Formula 1 Return to Argentina 
SoftBank Shares Jump 8% as SB Energy IPO Optimism Builds 
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts 
US Seizes Nearly 400 Illegal World Cup Streaming Domains in Global Anti-Piracy Crackdown 
Trump to Host UFC Event at White House on His 80th Birthday 
Volkswagen Job Cuts Put Lower Saxony Leader Under Political Pressure 
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks 
DOJ Launches Antitrust Investigation Into the NFL Over Broadcast Restrictions 
US Reviewing Visa Denial for Venezuelan Little League Team Barred from World Series 
Asian Bank Stocks Slide as BofA Warning and Rising Yields Hit Sentiment 
Trump Plans New Executive Order to Address Rising NIL Costs in College Sports 
Syngenta Files for Hong Kong IPO, Eyes $5 Billion Raise 
Samsung, SK Hynix Reject KEPCO’s $18.7 Billion Power Funding Plan 
Add as a preferred source on Google
The late Lakers icon Kobe Bryant's investment for a 10 percent stake in sports drink BodyArmor for just $6 million in the company way back in 2014 has grown to $800 million.
That incredible gain surpassed by two and a half times more Bryant’s career NBA earnings of roughly $323 million in his 20 seasons playing for the Los Angeles Lakers.
When Coca-Cola acquired a minority stake in the sports drink company in 2018, Bryant's shares immediately soared to around $200 million.
Coca-Cola is reportedly close to acquiring a controlling stake in sports BodyArmor for $8 billion, which could be announced as early as Monday.
The Lakers icon keeps proving that he excelled outside the court.
After Bryant retired from the NBA in 2016, his "Dear Basketball" production brought him an Oscar for the best animated short film.
